Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities of continuing operations:
Net income (loss)	$ (6,045,659)	$ (10,713,158)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	1,364,740	489,659
Amortization of debt discount	195,877	770,576
Common stock issued for financing costs	17,499	32,500
Common stock issued in exchange for fees and services	1,199,785	343,225
Deferred taxes	(35,389)	14,834
Earnout consideration realized in connection with acquisition of a business	362,500	0
Stock based compensation	2,658,633	8,080,998
Unrealized (gain) loss on change in fair value of contingent consideration	(1,502,707)	(2,055,895)
Changes in operating assets and liabilities:
Accounts receivable	104,758	143,261
Inventory	(36,068)	(40,162)
Prepaid expenses and other current assets	(232,720)	2,670
Other assets	(35,641)	3,608
Accounts payable	(89,246)	751,404
Accrued liabilities	74,619	113,646
Advanced payments and deferred revenues	315,728	(350,591)
Income taxes payable and other noncurrent liabilities	14,602	15,226
Related party payables	258,674	1,849,451
Net cash provided by (used in) operating activities	(1,410,015)	(548,748)
Cash flows from investing activities:
Cash consideration for acquisition of business	0	(3,500,000)
Cash acquired in acquisition of business	182	1,024,424
Purchase of fixed assets	(562,504)	(256,771)
Purchase of intangible assets	0	(20,521)
Net cash provided by (used in) investing activities	(562,322)	(2,752,868)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of issuance costs	0	340,076
Proceeds from exercise of common stock purchase warrants, net of issuance costs	1,566,000	1,251,000
Proceeds from issuance of convertible debentures	541,100	2,705,600
Proceeds from issuance of senior, secured promissory notes	32,000	0
Repayments of convertible debentures	(150,000)	0
Repayments of loans payable	0	(500,000)
Net cash provided by (used in) financing activities	1,989,100	3,796,676
Effect of exchange rates on cash and cash equivalents	(23,388)	(54,656)
Net increase (decrease) in cash and cash equivalents	(6,625)	440,404
Cash and cash equivalents at beginning of period	443,494	3,090
Cash and cash equivalents at end of period	436,869	443,494
Supplemental disclosure of cash flow information:
Cash paid for interest	0	0
Cash paid for income taxes	0	0
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued related to acquisition of business	147,000	4,240,000
Common stock issued with letter of intent to acquire a business	0	32,500
Common stock issued related to acquisition of intangible assets	60,000	162,500
Common stock issued for financing costs incurred in connection with convertible and promissory notes	78,321	667,332
Common stock issued in connection with long term service contracts	692,950	0
Common stock issued to reduce convertible and promissory notes payable	500,000	0
Common stock issued to reduce accounts payable and other accrued liabilities	33,000	150,000
Contingent purchase consideration	0	3,987,602
Conversion of convertible debentures and accrued interest into common stock	0	2,713,629
Debt issued related to acquisition of a business	1,000,000	4,500,000
Discount for beneficial conversion features on convertible debentures	60,123	67,917
Discount for fair value adjustment on promissory notes	$ 0	$ 309,049